| The challenge of antimicrobial resistance: what economics can contribute LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ... Science 364 (6435), eaau4679, 2019 | 414 | 2019 |
| Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people J Hippisley-Cox, D Young, C Coupland, KM Channon, P San Tan, ... Heart 106 (19), 1503-1511, 2020 | 383 | 2020 |
| Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study P Aveyard, M Gao, N Lindson, J Hartmann-Boyce, P Watkinson, D Young, ... The lancet Respiratory medicine 9 (8), 909-923, 2021 | 247 | 2021 |
| Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. CBDM SK Tonkin-Crine, PS Tan, O van Hecke, K Wang, NW Roberts, A McCullough ... The Cochrane database of systematic reviews 9, CD012252, 2017 | 222 | 2017 |
| Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort AK Clift, A Von Ende, P San Tan, HM Sallis, N Lindson, CAC Coupland, ... Thorax 77 (1), 65-73, 2022 | 173 | 2022 |
| Ten-year survival in women with primary stage IV breast cancer LG Eng, S Dawood, V Sopik, B Haaland, PS Tan, N Bhoo-Pathy, ... Breast cancer research and treatment 160, 145-152, 2016 | 124 | 2016 |
| Cost-effectiveness of Osimertinib in the first-line treatment of patients with EGFR-Mutated advanced non–Small cell lung Cancer PN Aguiar, B Haaland, W Park, P San Tan, A del Giglio, G de Lima Lopes JAMA oncology 4 (8), 1080-1084, 2018 | 116 | 2018 |
| Meta-analysis of first-line therapies in advanced non–small-cell lung cancer harboring EGFR-activating mutations B Haaland, P San Tan, G de Castro Jr, G Lopes Journal of Thoracic Oncology 9 (6), 805, 2014 | 113 | 2014 |
| Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B. 1.1. 7 in England: an observational cohort study M Patone, K Thomas, R Hatch, P San Tan, C Coupland, W Liao, ... The Lancet Infectious Diseases 21 (11), 1518-1528, 2021 | 103 | 2021 |
| Association between race and COVID-19 outcomes among 2.6 million children in England D Saatci, TA Ranger, C Garriga, AK Clift, F Zaccardi, P San Tan, M Patone, ... JAMA pediatrics 175 (9), 928-938, 2021 | 97 | 2021 |
| Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis JY Verbakel, JJ Lee, C Goyder, P San Tan, T Ananthakumar, PJ Turner, ... BMJ open 9 (1), e025036, 2019 | 73 | 2019 |
| Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer–A systematic review and network meta-analysis of 3024 … P San Tan, P Aguiar Jr, B Haaland, G Lopes Lung Cancer 115, 84-88, 2018 | 55 | 2018 |
| The clinical utility of point-of-care tests for influenza in ambulatory care: A systematic review and meta-analysis JJ Lee, JY Verbakel, CR Goyder, T Ananthakumar, PS Tan, PJ Turner, ... Clinical Infectious Diseases 69 (1), 24-33, 2019 | 48 | 2019 |
| Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases M Patone, K Thomas, R Hatch, PS Tan, C Coupland, W Liao, P Mouncey, ... MedRxiv, 2021.03. 11.21253364, 2021 | 37 | 2021 |
| A systematic review and meta-analyses of the association between anti-hypertensive classes and the risk of falls among older adults HT Ang, KK Lim, YH Kwan, PS Tan, KZ Yap, Z Banu, CS Tan, W Fong, ... Drugs & aging 35, 625-635, 2018 | 36 | 2018 |
| Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care IJ Onakpoya, AS Walker, PS Tan, EA Spencer, OA Gbinigie, J Cook, ... PloS one 13 (3), e0194858, 2018 | 36 | 2018 |
| Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a … PS Tan, P Aguiar, B Haaland, G Lopes Prostate cancer and prostatic diseases 21 (4), 516-523, 2018 | 35 | 2018 |
| Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study AK Clift, D Saatci, CAC Coupland, H Dambha-Miller, J Hippisley-Cox Annals of Internal Medicine 174 (9), 1483-1487, 2021 | 34 | 2021 |
| Meta‐analysis of first‐line therapies with maintenance regimens for advanced non‐small‐cell lung cancer (NSCLC) in molecularly and clinically selected populations PS Tan, M Bilger, G de Lima Lopes, S Acharyya, B Haaland Cancer medicine 6 (8), 1847-1860, 2017 | 28 | 2017 |
| Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison PS Tan, B Haaland, AJ Montero, CE Kyriakopoulos, G Lopes Clinical Medicine Insights: Oncology 8, CMO. S13671, 2014 | 27 | 2014 |
